| DAA890 |
IgM deposition in glomeruli |
Molecular |
glomerulus |
Human |
— |
— |
|
| DAA1997 |
DNA damage increases with age |
Molecular |
skin |
Human |
— |
— |
|
| DAA2042 |
Increase in IgA and IgM |
Molecular |
oral cavity |
Human |
— |
— |
|
| DAA1998 |
Lipid oxidation increased with age in males |
Molecular |
skin |
Human |
— |
— |
|
| DAA1065 |
efflux pump activity decreases |
Molecular |
blood brain barrier |
Human |
— |
— |
|
| DAA2056 |
MicroRNA let-7b expression upregulated |
Molecular |
skeletal muscle |
Human |
— |
— |
|
| DAA1224 |
MTHFR methylation decrease |
Molecular |
prefrontal cortex |
Human |
— |
— |
|
| DAA1966 |
Alox5 arachidonate 5-lipoxygenase (5-LOX) promoter methylation increase |
Molecular |
hippocampus |
Mouse |
— |
— |
|
| DAA1961 |
Intracellular NAD+ concentration decreases |
Molecular |
bone marrow |
Mouse |
— |
— |
|
| DAA1967 |
Alox5 arachidonate 5-lipoxygenase (5-LOX) mRNA expression increase |
Molecular |
cerebellum |
Mouse |
— |
— |
|
| DAA877 |
Higher oxidation and decreased proteasome activity |
Molecular |
epidermis |
Human |
— |
— |
|
| DAA2057 |
MicroRNA let-7e expression upregulated |
Molecular |
skeletal muscle |
Human |
— |
— |
|
| DAA1973 |
5-hmC increase in cerebrellum |
Molecular |
cerebellum |
Mouse |
— |
— |
|
| DAA2000 |
NAD(+) levels decrease with age |
Molecular |
skin |
Human |
— |
— |
|
| DAA1946 |
vitamin E levels decrease |
Molecular |
blood |
Mouse |
— |
— |
|
| DAA1067 |
transporter activity decreases |
Molecular |
blood brain barrier |
Human |
— |
— |
|
| DAA849 |
telomere shortening |
Molecular |
liver |
Human |
— |
— |
|
| DAA989 |
telomere shortening |
Molecular |
lymphocytes |
Human |
— |
— |
|
| DAA901 |
telomere shortening |
Molecular |
kidney |
Human |
— |
— |
|
| DAA959 |
telomere shortening |
Molecular |
naïve T cell |
Human |
— |
— |
|
| DAA1986 |
telomere shortening |
Molecular |
leukocyte |
Human |
— |
— |
|
| DAA673 |
telomere length in hematopoietic stem cells |
Molecular |
hematopoietic stem cells |
Human |
— |
— |
|
| DAA902 |
specific activities of enzymes are reduced |
Molecular |
kidney |
Human |
— |
— |
|
| DAA1231 |
decreased NF-KappaB induction in T cells |
Molecular |
T cell |
Human |
— |
— |
|
| DAA1232 |
decreased proteasomal activity in T cells |
Molecular |
T cell |
Human |
— |
— |
|